LATEST
Mon, Aug 31, 2026
Loading weather...
Business

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript

More details on this developing story will follow.

Original reporting: Seeking Alpha - Stock IdeasRead original report →
Have feedback on this article?Report error or suggestion

Read More from Business

Bronco Resources announces $450K private placement

Breaking News......

Read Article »

Activist Elliott builds stake in Air Liquide - FT (update)

Breaking News......

Read Article »

StubHub: Attractive Model, But I'm Staying On The Sidelines

Breaking News......

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.